According to Cognitive Market Research, the global congenital heart disease market size will be USD 4325.2 million in 2024. It will scale at a compound annual growth rate (CAGR) of 9.7% between 2024 and 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 1730.1 million in 2024 and will proceed at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 1297.6 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 994.8 million in 2024 and will climb at a compound annual growth rate (CAGR) of 11.7% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 216.3 million in 2024 and will evolve at a compound annual growth rate (CAGR) of 9.1% from 2024 to 2031.
Middle East & Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 86.5 million in 2024 and will progress at a compound annual growth rate (CAGR) of 9.4% from 2024 to 2031.
The echocardiogram category is the fastest-growing diagnosis segment of the congenital heart disease industry.
